Published in Virology on March 03, 2010
Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog (2010) 2.60
Cellular entry of ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog (2010) 2.60
The length of vesicular stomatitis virus particles dictates a need for actin assembly during clathrin-dependent endocytosis. PLoS Pathog (2010) 1.40
The Tyro3 receptor kinase Axl enhances macropinocytosis of Zaire ebolavirus. J Virol (2010) 1.36
Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis (2011) 1.33
Tyrosine kinase receptor Axl enhances entry of Zaire ebolavirus without direct interactions with the viral glycoprotein. Virology (2011) 1.22
The Ebola virus glycoprotein mediates entry via a non-classical dynamin-dependent macropinocytic pathway. Virology (2011) 1.22
Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs. Emerg Microbes Infect (2014) 1.18
Interplay between HIV entry and transportin-SR2 dependency. Retrovirology (2011) 1.17
Filovirus entry: a novelty in the viral fusion world. Viruses (2012) 1.03
Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles. J Infect Dis (2011) 0.99
Clathrin-mediated endocytosis and subsequent endo-lysosomal trafficking of adeno-associated virus/phage. J Biol Chem (2012) 0.94
Virtual screen for repurposing approved and experimental drugs for candidate inhibitors of EBOLA virus infection. F1000Res (2015) 0.94
The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge. Antiviral Res (2012) 0.92
A mutation in the Ebola virus envelope glycoprotein restricts viral entry in a host species- and cell-type-specific manner. J Virol (2013) 0.91
Differential requirements for clathrin endocytic pathway components in cellular entry by Ebola and Marburg glycoprotein pseudovirions. Virology (2011) 0.89
Streptococcus pneumoniae invades endothelial host cells via multiple pathways and is killed in a lysosome dependent manner. PLoS One (2013) 0.88
Rab1a regulates sorting of early endocytic vesicles. Am J Physiol Gastrointest Liver Physiol (2014) 0.87
Full-length Ebola glycoprotein accumulates in the endoplasmic reticulum. Virol J (2011) 0.85
Selective Inhibitors of Cyclin G Associated Kinase (GAK) as Anti-Hepatitis C Agents. J Med Chem (2015) 0.85
Hijacking the endocytic machinery by microbial pathogens. Protoplasma (2010) 0.84
Ebola virus entry into host cells: identifying therapeutic strategies. Curr Clin Microbiol Rep (2015) 0.82
Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors. PLoS One (2013) 0.81
AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus. J Virol (2012) 0.80
Endocytic pathways involved in filovirus entry: advances, implications and future directions. Viruses (2012) 0.79
Altered protein networks and cellular pathways in severe west nile disease in mice. PLoS One (2013) 0.79
Retrovirus entry by endocytosis and cathepsin proteases. Adv Virol (2012) 0.79
Cell Walls and the Convergent Evolution of the Viral Envelope. Microbiol Mol Biol Rev (2015) 0.77
Synthesis of the Pitstop family of clathrin inhibitors. Nat Protoc (2014) 0.76
Unraveling protein-protein interactions in clathrin assemblies via atomic force spectroscopy. Methods (2012) 0.76
Scavenger Receptor C Mediates Phagocytosis of White Spot Syndrome Virus and Restricts Virus Proliferation in Shrimp. PLoS Pathog (2016) 0.75
Cellular factors implicated in filovirus entry. Adv Virol (2013) 0.75
KSHV Entry and Trafficking in Target Cells-Hijacking of Cell Signal Pathways, Actin and Membrane Dynamics. Viruses (2016) 0.75
Subcellular fractionation method to study endosomal trafficking of Kaposi's sarcoma-associated herpesvirus. Cell Biosci (2016) 0.75
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol Res Perspect (2017) 0.75
Regulated portals of entry into the cell. Nature (2003) 15.33
Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci U S A (1988) 10.77
pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane. Cell (1987) 9.29
The trans-activator gene of HTLV-III is essential for virus replication. Nature (1986) 8.65
Hypertonic media inhibit receptor-mediated endocytosis by blocking clathrin-coated pit formation. J Cell Biol (1989) 6.76
Clathrin-mediated endocytosis in AP-2-depleted cells. J Cell Biol (2003) 6.35
Mis-assembly of clathrin lattices on endosomes reveals a regulatory switch for coated pit formation. J Cell Biol (1993) 5.62
Pathway of vesicular stomatitis virus entry leading to infection. J Mol Biol (1982) 5.21
Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J Virol (1998) 5.16
Inhibition of clathrin-coated pit assembly by an Eps15 mutant. J Cell Sci (1999) 4.36
Analysis of clathrin-mediated endocytosis of epidermal growth factor receptor by RNA interference. J Biol Chem (2004) 4.32
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Ligands for clathrin-mediated endocytosis are differentially sorted into distinct populations of early endosomes. Cell (2006) 3.83
Influenza virus can enter and infect cells in the absence of clathrin-mediated endocytosis. J Virol (2002) 2.78
Assembly of endocytic machinery around individual influenza viruses during viral entry. Nat Struct Mol Biol (2004) 2.77
Ebola virus: from discovery to vaccine. Nat Rev Immunol (2003) 2.72
Descriptive analysis of Ebola virus proteins. Virology (1985) 2.65
Adenovirus triggers macropinocytosis and endosomal leakage together with its clathrin-mediated uptake. J Cell Biol (2002) 2.64
Human immunodeficiency virus type 1 uses lipid raft-colocalized CD4 and chemokine receptors for productive entry into CD4(+) T cells. J Virol (2002) 2.49
Listeria hijacks the clathrin-dependent endocytic machinery to invade mammalian cells. Nat Cell Biol (2005) 2.45
Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell (2001) 2.39
Clathrin assembly proteins: affinity purification and a model for coat assembly. J Cell Biol (1987) 2.34
Generation of eGFP expressing recombinant Zaire ebolavirus for analysis of early pathogenesis events and high-throughput antiviral drug screening. Virology (2005) 2.25
Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology (2005) 2.24
Folate receptor alpha and caveolae are not required for Ebola virus glycoprotein-mediated viral infection. J Virol (2003) 2.11
Early events in the infection of human B lymphocytes by Epstein-Barr virus: the internalization process. Virology (1984) 2.11
Infectious entry pathway of adenovirus type 2. J Virol (1991) 2.06
Filoviridae: a taxonomic home for Marburg and Ebola viruses? Intervirology (1982) 1.89
Role of vesicles during adenovirus 2 internalization into HeLa cells. J Virol (1985) 1.81
Kinetics of transit of transferrin and epidermal growth factor through clathrin-coated membranes. Cell (1984) 1.78
Clathrin exchange during clathrin-mediated endocytosis. J Cell Biol (2001) 1.76
Association of the caveola vesicular system with cellular entry by filoviruses. J Virol (2002) 1.72
Human immunodeficiency virus type 1 particles pseudotyped with envelope proteins that fuse at low pH no longer require Nef for optimal infectivity. J Virol (2001) 1.65
Characterization of rotavirus cell entry. J Virol (2004) 1.46
Analysis of filovirus entry into vero e6 cells, using inhibitors of endocytosis, endosomal acidification, structural integrity, and cathepsin (B and L) activity. J Infect Dis (2007) 1.46
Lentivirus vectors pseudotyped with filoviral envelope glycoproteins transduce airway epithelia from the apical surface independently of folate receptor alpha. J Virol (2003) 1.45
Mapping of Eps15 domains involved in its targeting to clathrin-coated pits. J Biol Chem (2000) 1.44
Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts. J Virol (2005) 1.23
Lipid raft microdomains: key sites for Coxsackievirus A9 infectious cycle. Virology (2003) 1.18
Virion nucleic acid of Ebola virus. J Virol (1980) 1.15
Adenovirus-induced leakage of co-endocytosed macromolecules into the cytosol. Cell Struct Funct (1985) 1.00
Inhibition by phenothiazine antipsychotic drugs of calcium-dependent phosphorylation of cerebral cortex proteins regulated by phospholipid or calmodulin. Life Sci (1981) 0.97
Caveolae as an additional route for influenza virus endocytosis in MDCK cells. Cell Mol Biol Lett (2004) 0.93
Drug-protein interactions: binding of chlorpromazine to calmodulin, calmodulin fragments, and related calcium binding proteins. Biochemistry (1985) 0.92
Effects of intermediate filaments on actin-based motility of Listeria monocytogenes. Biophys J (2001) 0.87
Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials. BMC Med (2005) 0.86
Chlorpromazine modulates the morphological macro- and microstructure of endothelial cells. Am J Physiol Cell Physiol (2000) 0.81
Antibacterial effect of four phenothiazines. Pharmacol Toxicol (1987) 0.76
Visualization of the intracellular behavior of HIV in living cells. J Cell Biol (2002) 6.59
Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell (2008) 6.37
Recruitment of HIV and its receptors to dendritic cell-T cell junctions. Science (2003) 6.22
Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature (2011) 5.68
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation. Nature (2010) 3.96
Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88
Actin is part of pre-initiation complexes and is necessary for transcription by RNA polymerase II. Nat Cell Biol (2004) 3.43
Proteasome inhibitors uncouple rhesus TRIM5alpha restriction of HIV-1 reverse transcription and infection. Proc Natl Acad Sci U S A (2006) 3.43
Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog (2011) 3.26
Advanced antisense therapies for postexposure protection against lethal filovirus infections. Nat Med (2010) 3.25
Ebola and Marburg viruses replicate in monocyte-derived dendritic cells without inducing the production of cytokines and full maturation. J Infect Dis (2003) 3.15
Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog (2007) 2.75
Ebola virus-like particle-based vaccine protects nonhuman primates against lethal Ebola virus challenge. J Infect Dis (2007) 2.68
Evaluation of perceived threat differences posed by filovirus variants. Biosecur Bioterror (2011) 2.62
Conserved receptor-binding domains of Lake Victoria marburgvirus and Zaire ebolavirus bind a common receptor. J Biol Chem (2006) 2.56
Rotavirus antigenaemia and viraemia: a common event? Lancet (2003) 2.51
Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus. J Virol (2009) 2.49
Designing a biocontainment unit to care for patients with serious communicable diseases: a consensus statement. Biosecur Bioterror (2006) 2.43
Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization. Proc Natl Acad Sci U S A (2005) 2.35
Proteasome inhibition reveals that a functional preintegration complex intermediate can be generated during restriction by diverse TRIM5 proteins. J Virol (2006) 2.32
In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc Natl Acad Sci U S A (2003) 2.32
Ebola virus-like particles protect from lethal Ebola virus infection. Proc Natl Acad Sci U S A (2003) 2.18
HIV infection of the genital mucosa in women. Curr HIV/AIDS Rep (2009) 2.18
Ebola virus entry requires the host-programmed recognition of an intracellular receptor. EMBO J (2012) 2.08
Complementary assays reveal a relationship between HIV-1 uncoating and reverse transcription. Proc Natl Acad Sci U S A (2011) 2.08
Disruption of the actin cytoskeleton can complement the ability of Nef to enhance human immunodeficiency virus type 1 infectivity. J Virol (2004) 2.06
Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers. PLoS Pathog (2006) 2.01
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog (2012) 2.00
Labeling HIV-1 virions with two fluorescent proteins allows identification of virions that have productively entered the target cell. Virology (2006) 1.97
Visualization of a proteasome-independent intermediate during restriction of HIV-1 by rhesus TRIM5alpha. J Cell Biol (2008) 1.88
Identification of small molecule inhibitors of anthrax lethal factor. Nat Struct Mol Biol (2003) 1.86
Keratinization of the adult male foreskin and implications for male circumcision. AIDS (2010) 1.85
Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis (2005) 1.82
Association of chemokine-mediated block to HIV entry with coreceptor internalization. J Biol Chem (2002) 1.79
The evolving field of biodefence: therapeutic developments and diagnostics. Nat Rev Drug Discov (2005) 1.79
Dendritic cells endocytose Bacillus anthracis spores: implications for anthrax pathogenesis. J Immunol (2005) 1.78
Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections. Clin Vaccine Immunol (2008) 1.78
Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5. Blood (2010) 1.72
Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection. J Immunol (2005) 1.69
Novel broad-spectrum bis-(imidazolinylindole) derivatives with potent antibacterial activities against antibiotic-resistant strains. Antimicrob Agents Chemother (2009) 1.66
VP35 knockdown inhibits Ebola virus amplification and protects against lethal infection in mice. Antimicrob Agents Chemother (2006) 1.63
Development and characterization of a mouse model for Marburg hemorrhagic fever. J Virol (2009) 1.62
Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59
Generation of Marburg virus-like particles by co-expression of glycoprotein and matrix protein. FEMS Immunol Med Microbiol (2004) 1.58
Greentree white paper: sexual violence, genitoanal injury, and HIV: priorities for research, policy, and practice. AIDS Res Hum Retroviruses (2012) 1.52
3D visualization of HIV transfer at the virological synapse between dendritic cells and T cells. Proc Natl Acad Sci U S A (2010) 1.52
HIV-1 infection of human penile explant tissue and protection by candidate microbicides. AIDS (2009) 1.49
Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin. J Virol (2010) 1.48
Activated CD34-derived Langerhans cells mediate transinfection with human immunodeficiency virus. J Virol (2007) 1.47
TRIM5 alpha cytoplasmic bodies are highly dynamic structures. Mol Biol Cell (2007) 1.47
Inhibition of metalloprotease botulinum serotype A from a pseudo-peptide binding mode to a small molecule that is active in primary neurons. J Biol Chem (2006) 1.47
Mechanical tension can specify axonal fate in hippocampal neurons. J Cell Biol (2002) 1.46
Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. J Infect Dis (2004) 1.44
Role of natural killer cells in innate protection against lethal ebola virus infection. J Exp Med (2004) 1.44
Virus-like particles exhibit potential as a pan-filovirus vaccine for both Ebola and Marburg viral infections. Vaccine (2005) 1.44
Lower antibody levels to Staphylococcus aureus exotoxins are associated with sepsis in hospitalized adults with invasive S. aureus infections. J Infect Dis (2012) 1.40
IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol (2013) 1.39
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents. PLoS One (2013) 1.38
Anthrax biosensor, protective antigen ion channel asymmetric blockade. J Biol Chem (2005) 1.37
Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity. Biochem Biophys Res Commun (2003) 1.34
Defining the interaction of HIV-1 with the mucosal barriers of the female reproductive tract. J Virol (2013) 1.31
Managing potential laboratory exposure to ebola virus by using a patient biocontainment care unit. Emerg Infect Dis (2008) 1.30
Development of a model for marburgvirus based on severe-combined immunodeficiency mice. Virol J (2007) 1.30
Localization of CD4 and CCR5 in living cells. J Virol (2003) 1.28
Ebola virus genome plasticity as a marker of its passaging history: a comparison of in vitro passaging to non-human primate infection. PLoS One (2012) 1.28
Modulation of Viscoelasticity and HIV Transport as a Function of pH in a Reversibly Crosslinked Hydrogel. Adv Funct Mater (2009) 1.28
Cytotoxic T cells mediate pathology and metastasis in cutaneous leishmaniasis. PLoS Pathog (2013) 1.28
Generation of protective immunity by inactivated recombinant staphylococcal enterotoxin B vaccine in nonhuman primates and identification of correlates of immunity. Clin Immunol (2003) 1.27
Chemical modifications of antisense morpholino oligomers enhance their efficacy against Ebola virus infection. Antimicrob Agents Chemother (2009) 1.26
Assembly of a functional Machupo virus polymerase complex. Proc Natl Acad Sci U S A (2010) 1.24
Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses. Expert Rev Vaccines (2008) 1.23
Discovery and early development of AVI-7537 and AVI-7288 for the treatment of Ebola virus and Marburg virus infections. Viruses (2012) 1.23